Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  NMCD. Nutrition Metabolism and Cardiovascular Diseases

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.numecd.2009.10.016PMID 20153613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosus.

  2009cited by this paper
• Management of antiphospholipid antibody syndrome.

  2009cited by this paper
• 25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies

  2009cited by this paper
• Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects

  2009cited by this paper
• High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.

  2009cited by this paper
• Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No

  2008cited by this paper
• Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies

  2008cited by this paper
• Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)

  2008cited by this paper
• Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

  2008influential reference
• Update on antiphospholipid syndrome.

  2008influential reference
• Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.

  2008cited by this paper
• The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients

  2007cited by this paper
• Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism

  2007cited by this paper
• Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

  2007cited by this paper
• Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.

  2007cited by this paper
• Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients

  2007influential reference
• Management of antiphospholipid antibody syndrome: a systematic review.

  2006influential reference
• A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

  2005cited by this paper
• Pathophysiology of the antiphospholipid syndrome

  2005cited by this paper
• IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.

  2005cited by this paper
• Diagnosis of antiphospholipid syndrome

  2005cited by this paper
• beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome.

  2004cited by this paper
• Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

  2004influential reference
• Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome.

  2003cited by this paper
• New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations.

  2003cited by this paper
• A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

  2003cited by this paper
• Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.

  2003cited by this paper
• Antiphospholipid syndrome

  2003cited by this paper
• Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.

  2002cited by this paper
• The antiphospholipid syndrome.

  2002influential reference
• High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.

  2001cited by this paper
• The G1691 → A mutation of factor V, but not the G20210 → A mutation of factor II or the C677 → T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants

  2000cited by this paper
• Preservation of the Chief Medical Residency

  1998cited by this paper
• The Contribution of Anti-prothrombin-antibodies to Lupus Anticoagulant Activity

  1998cited by this paper
• Monitoring warfarin therapy in patients with lupus anticoagulants.

  1997cited by this paper
• Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

  1996cited by this paper
• Antiphospholipid-protein antibodies: laboratory detection and clinical relevance.

  1995cited by this paper
• The management of thrombosis in the antiphospholipid-antibody syndrome.

  1995cited by this paper
• A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study.

  1994cited by this paper
• Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

  1993cited by this paper
• Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

  1992cited by this paper
• Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

  1992cited by this paper
• Lupus anticoagulant and anticardiolipin antibodies in an obstetric population

  1992cited by this paper
• The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study

  1991cited by this paper
• Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies

  1990cited by this paper

• Aptamer-based protein molecule detection via cyclic reverse transcription coupling with self-priming hairpin-triggered CRISPR-Cas12a system

  2024cites this paper
• Stroke Secondary to an Intra-Carotid Thrombus in a Context of Antiphospholipid Syndrome and Thrombocytosis: Report of a Case

  2024cites this paper
• Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis.

  2020cites this paper
• Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study.

  2019cites this paper
• Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies

  2019cites this paper
• Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study.

  2018cites this paper
• The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies.

  2018cites this paper
• Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies

  2014cites this paper
• Cardiovascular Involvement in Autoimmune Diseases

  2014cites this paper
• Cardiovascular comorbidities in antiphospholipid syndrome.

  2013cites this paper
• Zakrzepica żylna i tętnicza jako objaw zespołu antyfosfolipidowego

  2013cites this paper
• Cardiovascular comorbidities in antiphospholipid syndrome

  2013cites this paper
• Transient Global Amnesia as the First Symptom of Primary Antiphospholipid Syndrome: A Case Report

  2012cites this paper
• Comparison of Serum Level of Antiphospholipid Antibodies and Homocysteine in Patients with Pemphigus Vulgaris and Healthy Subjects

  2010cites this paper